• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定的中等纯度因子VIII浓缩物的制备及关于高纯度因子VIII的说明

Preparation of stable intermediate-purity factor VIII concentrate with a note on high-purity factor VIII.

作者信息

Margolis J, Rhoades P

出版信息

Vox Sang. 1979;36(6):369-74. doi: 10.1111/j.1423-0410.1979.tb04514.x.

DOI:10.1111/j.1423-0410.1979.tb04514.x
PMID:494575
Abstract

Cryoprecipitate prepared by a rapid thawing technique was pooled in batches of 600--720 donor units and washed with ice-cold Tris-citrate-NaCl solution. After dissolving at 37 degrees C, it was adsorbed with Al(OH)3 and kaolin, and cleared by centrifugation. The supernatant, diluted with 5% dextrose was passed repeatedly through a bed of Celite, filtered through a 293 mm X 0.3 micrometer membrane disc and lyophilized. Typical composition was 15 U . ml-1 factor VII, and 40 mg . ml-1 protein with a yield of 300 U/l of starting plasma. The crude factor VIII concentrate was also a suitable material for preparation of high-purity factor VIII by controlled pore glass chromatography.

摘要

采用快速解冻技术制备的冷沉淀,按600 - 720个供体单位一批进行汇集,并用冰冷的柠檬酸三钠 - 氯化钠溶液洗涤。在37℃溶解后,用氢氧化铝和高岭土吸附,然后离心澄清。上清液用5%葡萄糖稀释后,反复通过硅藻土柱,经293mm×0.3微米的膜盘过滤并冻干。典型成分是每毫升含15单位的凝血因子VII和每毫升40毫克蛋白质,起始血浆的产率为每升300单位。粗制的凝血因子VIII浓缩物也是通过可控孔径玻璃色谱法制备高纯度凝血因子VIII的合适材料。

相似文献

1
Preparation of stable intermediate-purity factor VIII concentrate with a note on high-purity factor VIII.稳定的中等纯度因子VIII浓缩物的制备及关于高纯度因子VIII的说明
Vox Sang. 1979;36(6):369-74. doi: 10.1111/j.1423-0410.1979.tb04514.x.
2
Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.对人类血液合理利用的贡献。VII. 通过改进血液和血浆处理方法提高四供体冷沉淀中凝血因子VIII的产量
Vox Sang. 1976;30(1):1-22. doi: 10.1111/j.1423-0410.1976.tb04830.x.
3
Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.由肝素化血浆制备的热处理凝血因子VIII/血管性血友病因子浓缩物的研发。
Thromb Haemost. 1990 Jun 28;63(3):392-402.
4
Modified glycine precipitation technique for the preparation of factor VIII concentrate of high purity and high stability.用于制备高纯度和高稳定性凝血因子 VIII 浓缩物的改良甘氨酸沉淀技术。
Vox Sang. 1987;52(1-2):10-4. doi: 10.1111/j.1423-0410.1987.tb02980.x.
5
A process for preparation of 'high-purity' factor VIII by controlled pore glass treatment.一种通过可控孔径玻璃处理制备“高纯度”凝血因子 VIII 的方法。
Vox Sang. 1984;46(6):341-8. doi: 10.1111/j.1423-0410.1984.tb00097.x.
6
A heat-treated factor VIII concentrate prepared by controlled-pore glass adsorption chromatography.一种通过可控孔径玻璃吸附色谱法制备的热处理凝血因子VIII浓缩剂。
Transfusion. 1987 Mar-Apr;27(2):174-7. doi: 10.1046/j.1537-2995.1987.27287150194.x.
7
Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.改良冷沉淀凝血因子 VIII 浓缩物的制备。对影响产量的三个变量的对照研究。
Vox Sang. 1980;38(4):222-8. doi: 10.1111/j.1423-0410.1980.tb02358.x.
8
Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.在封闭的解冻虹吸系统中,由去氨加压素刺激的献血者血浆制备的中等纯度冷沉淀。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(4):565-70.
9
Controlled pore glass factor VIII concentrate: influence of heat treatment.可控孔径玻璃因子VIII浓缩物:热处理的影响。
Pathology. 1987 Jan;19(1):56-7. doi: 10.3109/00313028709065136.
10
Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.在封闭系统解冻虹吸过程中生产中等纯度的冷沉淀。
Thromb Haemost. 1981 Aug 28;46(2):543-6.